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Abstract
Introduction: Sporadic Creutzfeldt-Jakob disease (sCJD) might be transmitted by surgery. The purpose of this study was to
investigate potential susceptibility to sCJD from surgery at juvenile age and in early adulthood.
Methods: From Danish and Swedish national registries we identified 167 definite and probable sCJD cases with onset from
1987 through 2003, and 835 age-, sex- and residence-matched controls along with their surgical histories. Main,
anatomically or etiologically classified surgical procedures followed by a $20-year lag were analyzed using logistic
regression, and stratified by age at first-registered surgical discharge.
Results: The risk of having a diagnosis of CJD depended strongly on age at first surgery with odds ratio (OR) of 12.80 (95% CI
2.56–64.0) in patients ,30 years, 3.04 (95% 1.26–7.33) in 30–39 years, and 1.75 (95% CI 0.89–3.45) in $40 years, for
anatomically classified surgical procedures. Similar figures were obtained for etiologically classified surgical procedures.
Conclusions: Risk of surgical-acquired sCJD depends on age at exposure; this pattern is similar to age-specific profiles
reported for CJD accidentally transmitted by human pituitary-derived growth hormone and susceptibility curves for variant
CJD estimated after adjustment for dietary exposure to bovine spongiform encephalopathy. There might be an age-at-
exposure-related susceptibility to acquire all CJD forms, including sCJD from routine surgery.
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Funding: Funding was obtained from the EU Research Commission, Concerted Action QLRG3-CT-2002-81223, NEUROPRION and the Spanish Centro de
Investigaciones en enfermedades Neurológicas (CIEN C03-06), and Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED) networks, and
from the Karolinska and Carlos III National Health Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: jpedro@isciii.es
" Membership of the EUROSURGYCJD Research Group is provided in the Acknowledgments.
Introduction
Sporadic Creutzfeldt-Jakob disease (sCJD) is the most frequent
neurodegenerative condition among the rare human transmissible
spongiform encephalopathies. It has an annual incidence of 1–2
per million and is found worldwide [1]. Other CJD forms include
genetic CJD, caused by mutations in the gene encoding PrP
(PRNP); acquired, ie, accidentally transmitted or iatrogenic CJD
(iCJD); and variant CJD (vCJD). iCJD has been reported to be
transmitted by neurosurgical instruments used on persons
incubating or clinically presenting with CJD, by dura mater
grafts, or by treatment with human pituitary hormones. While
vCJD has been linked both to dietary exposure to bovine
spongiform encephalopathy (BSE) and, more rarely, to transfusion
of blood from infected donors, it has not been associated with
either general or dental surgery (see reference [2] for a review).
Lastly, Kuru, a disease described among the Fore people of Papua
New Guinea, has been attributed to ritual cannibalistic practices
by natives [1]. The pathogenesis of vCJD transmission by surgery,
including neurosurgery in particular, is still being considered. In all
forms of CJD, disease progression and cellular death is determined
by cell-to-cell transmission of a pathologic isoform (termed PrPSc)
of the normal prion protein (PrPC), both denoted in amyloid fibril
protein nomenclature as APrP [3].
The cause of sCJD is still poorly understood. A number of
studies report no association or report even protective effects of
surgery, including neurosurgery (see references [2,4] for reviews).
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Several of these studies may be subject to bias, and there is
increasing epidemiologic evidence of associations to history of
general surgery [5,6], with long incubation periods [6], surgery of
the retina and peripheral nerves after shorter incubation intervals
[7], and, with less consistent results, to blood transfusion
connected to surgery after a .10-year lag [8,9]. Experimental
evidence suggests that infectious PrPSc bound to the surface of
instruments reused during major surgical interventions may
transmit CJD despite repeated cleaning and sterilization following
previous prion-unaware protocols [10]. Taken together, indicate
that a proportion of sCJD may indeed have been accidentally
transmitted in origin [5–8].
A variation in risk of sCJD in strata by age at clinical onset was
reported using matched controls (MCs), unmatched controls, and
latency analysis [6]. Excess risk was higher for cases with onset at
ages ,68 years than for those with onset at ages $68 years; these
case-groups differed in age at first-registered surgery undergone $
20 years prior to CJD onset, ie, (mean, SD) 34.0, 7.2 years vs 51.5,
4.2 years, respectively [6]. A plausible interpretation for such
variation was the presence of effect modification by surgery
undergone at earlier ages, due to age-related biologic host
susceptibility.
The aim of the present study, pursuing the same line of
investigation as two preceding reports [6,7], was to use the same
database to quantify the variation in surgical risk of sCJD
potentially determined by age at surgery.
Materials and Methods
The study was designed as a registry-based case-control study
and has previously been described in detail elsewhere [6,7]. We
included 167 probable or definite sCJD cases who, after being
identified from surveillance and death registries, fulfilled estab-
lished diagnostic criteria, showed clinical onset during the period
1987–2003, and resided in Denmark or Sweden [7]. A population-
control set comprising 835 controls matched by gender, year and
month of birth, and municipality of residence at death of the
corresponding case (5 matched controls (MCs) per case), were
randomly sampled from the national study populations aged 40
years and over resident during the abovementioned study period
[6,7]).
Our analysis was restricted to surgical interventions that were
followed by long latency periods. Using the body-system classifi-
cation of surgical procedures (SPs), exposure was defined as first
major SP linked to a discharge preceding the clinical onset of
illness for cases or the corresponding index date for controls (ID-2)
by at least 20 years. We identified main surgical procedures, ie,
those SPs remaining after excluding subsidiary procedures (such as
punctures, transluminal endoscopic procedures and others), see
Table 1 foot notes, associated with hospital discharge preceding
the operational time point for onset or ID-2 by $20 years. Age at
discharge was calculated and assumed to represent age at surgical
intervention, disregarding the number of SPs coded per discharge.
When the main SPs had been etiologically classified and grouped
by presumed risk level using a reported method [7], analyses were
performed for presumed higher-risk and lower-risk SPs at the
above lag ($20 years). Conditional logistic regression was used to
determine the odds ratio (OR) in three age strata defined by age at
first-registered surgical discharge followed by the abovementioned
$20-year lag, ie, ,30, 30–39, and $40 years. Results were
tabulated and, for purposes of interpretation, those for age-at-first-
surgical-discharge strata were plotted on a graph which also
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Scientific evaluation and preliminary ethical clearance of the
research proposal was done by the EU Research Commission’s
‘‘Concerted Action QLRG3-CT-2002-81223’’. The study was
formally notified to the Danish Data Protection Agency (record
no. 2003-41-3104) and approved by the Karolinska Institute
Ethics Committee (South; report no. 452/02, 2002-12-02) and
"Regionala Etiskprövningsnämnden" dnr 04-171T 2004-04-29 1).
Written consent was not given by patients for their information to
be stored in the hospital data base and used for research since it
was not needed. In Sweden, patients were never personally
identified after register linkage took place by registries adminis-
trative officers. A data base was built after substituting at registries
level each personal identification number by serial individual
numbers. Data stored in official Swedish registries were used
following legal regulations. The study conforms with Danish
legislation requiring data management after notification to the
Danish Data Protection Agency (Act on Processing of Personal
Data - Act No. 429 of 31 May 2000). According to the Danish
legislation, there is no need for scientific-ethical clearance of
registry based studies, nor is there a need for written consent by
cases (Act nr 593 of 14/06/2011, Section 10 paragraph 2).
Additionally all CJD patients had died by the time of data
collection. No biological or tissue data was studied. The dataset is
available on request to last author.
Results
This analysis included 123 study participants, made up of 33
cases, and 90 MCs with a record of surgery and documented age
at discharge. The remaining 879 persons included in the database,
134 cases and 745 MCs, were free of such surgery. History of
surgery followed by a $20-year lag was associated with significant
excess risk of sCJD, with similar estimates for anatomically and
etiologically classified SPs (ORs of 2.44 and 2.81, respectively; see
Table 1). The risks at this latency for age at first-registered surgical
discharge for main anatomically classified SPs yielded ORs of
12.80, 3.04, and 1.75 when comparing persons first exposed at
ages ,30, 30–39, and $40 years, respectively. A similar trend,
with higher risk in the lowest age-category, was seen when
etiologically reclassified higher- and lower-risk procedures were
compared (ORs of 13.2, 3.57, and 2.10 for ages ,30, 30–39, and
$40 years, respectively). The patterns obtained in our study
suggest an increasing risk with decreasing age at first-registered
surgery, particularly in the case of the ,30-year age stratum. The
ORs for each of three categories of age at first-registered surgery at
a $20-year lag for main SPs, specified in Table 1 are graphically
shown in Figure 1.
A complementary analysis using an alternative set of models,
with categories of age at first surgical exposure with a 20-year lag
in quintiles, yielded similar results. For the lowest quintile, the OR
for anatomically classified main procedures, with 8 exposed cases
and 17 exposed MCs, mean age 27.5 years, was 5.15 (95% CI
1.58–16.8). For etiologically classified main SPs, with 5 exposed
cases and 12 exposed MCs, mean age 28.5 years, the OR was 3.53
(95% CI 0.88–14.3). Mean ages for the lowest quintile were higher
than for the corresponding ,30-year group.
Discussion
This study represents the fourth sequential approach to
quantifying associations between surgery and sCJD, using unique
material and purpose-designed methods [6,7,14–16]. Study
strength is indicated by the systematic use of registries, which
allowed for less-biased assessment of exposure variables (SPs) and
for validated outcomes [17]. Interpretation of results may have
been affected by methodologic limitations, including lack of
control of confounding due to blood transfusion (BT). The fact
that the frame of biological plausibility for a causal interpretation
of results is limited, owing to the relative infrequency of
neurosurgical procedures in this dataset (only one such SP,
peripheral nerve surgery due to amputation, among cases was
included) does not preclude inference for general surgery.
Excess risk in age-at-first-registered-surgery strata
We found an age-at-exposure risk pattern which mimics that
reported for vCJD. This is consistent with the possibility of an age-
related common biologic-etiologic determinant of risk for different
CJD forms, possibly neglected until now. This pattern is in
agreement with the currently accepted notion of susceptibility, ie,
different effects from a given exposure [2,18]. Since SP registration
was first introduced in 1970 in Denmark and in the early 1970s in
most Swedish counties [19], effects observed by our study among
those exposed earliest in life might have incorporated risk acquired
from unregistered surgery undergone at even lower ages.
Attributing an age-at-exposure differential excess risk to age-at-
exposure susceptibility would require that the nature of surgical
exposure or preventive practices did not vary with age. The weight
of reproductive surgery was similar across age groups. Addition-
ally, excess risk of reproductive-organ surgery was similar to that
seen for other types of surgery, such as gastrointestinal or
orthopedic, at the same latency [6]. Tonsillectomy, of which rates
are known to vary by age was unfrequently registered, i.e. in two
controls at ages 26 and 56 years. One case had tonsil incision at 28
years. Such unprecise data would correspond to a fivefold higher
proportion of tonsil-related surgery among cases in the youngest
age-group. It is nonetheless likely that other cases and controls
underwent tonsillectomy at .20-year lag as outpatients. This
underascertainment of exposures represents a limitation. Based on
the same material, we previously estimated a modest and
unprecise excess risk for surgery related to the tonsils OR 3.59
(95% CI 0.39 to 32.8) [7]. Recapitulating, results for tonsillectomy
are not fully in line with the high risk for surgery at ages 23.9–29.5
years seen in the present study; this can be ascribed to low
numbers but it is also possible that hospital cleaning and
disinfection practices, including increase use of single-use materi-
als, have improved in recent decades, when registered surgery at
youngest ages was most frequent. Such an expected effect will tend
to dilute our main finding, i.e., a higher risk among the young, and
could, in addition to the issue of low numbers, explain the previous
observation on procedures related to the tonsils [7].
Age-related susceptibility to exposure effects in other
CJD forms
Age-related susceptibility to the effects of dietary exposure to
BSE in the United Kingdom (UK) constitutes a key etiologic and
epidemiologic feature of vCJD [12,13] supported by the recently
suggested role of the phosphatidylinositol pathway [20]. As can be
seen in Figure 1-a and 1-b, reported data on age-specific risk of
vCJD in the UK, whether estimated as a susceptibility function or
calculated by Böelle et al. after adjustment for age-specific
magnitude of dietary exposure to BSE, approximately depict
log-normal functions [12,13]. Additionally, a variation in risk of
iCJD by age at treatment with cadaveric pituitary-derived growth
hormone (hGH), ie, ever versus never treated in each age category,
has been suggested from a descriptive report on iCJD incidence
rates in UK cohorts, see Figure 1-c and 1-d [11]. The highest rates
were seen among persons treated at age nine years with hGH
prepared by the Wilhelmi method of extraction, and at later ages,
for all hGH treatments [11]. When these data were plotted on
Age-Dependent Induction of Acquired and Sporadic CJD
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Figure 1, a tantalizing visual interpretation suggested that the
iCJD curve matched the vCJD risk-function profile at its highest-
risk age interval. Age-related susceptibility for iCJD due to dura
mater grafts has not been suggested despite many iCJD patients
received grafts at young age with long survival, for instance
associated with posterior fossa surgery on malformations. The high
ratio of approximately one iCJD case per 2000 grafts [21]
indicates that there is room for age-related susceptibility for iCJD
due to dura mater.
On the basis of the above limited, though detailed, data for
iCJD, sCJD, and vCJD, a general model of age-related
susceptibility to CJD could be hypothesized.
Surgical history and risk of sCJD
A recent review of 18 case-control studies which examined links
between medical procedures, particularly surgery and blood
transfusion, and sCJD, identified many other associations,
including protective ones, and highlighted diverse sources of
potentially underlying bias [2]. The review concluded that
potential methodological pitfalls in case-control studies on surgery
and risk of sCJD were (a) the use of hospital controls and sampling
controls close to or at the end of long case incidence periods, (b)
exposure assessment in different lifetime periods for cases and
controls and (c) potential confounding by concurrent procedures,
particularly surgery and intra-operative blood transfusions. Three
types of positive associations with decreasing biological plausibility
were proposed. a) An increased frequency of surgery during the
prodromal phase or early clinical course in sCJD was considered
to be a stressful trigger of sCJD [22] or, alternatively, attributed to
reverse causality by prodromal or subclinical disease [14]. b)
Positive associations for SP and blood tranfusions, with the
strongest evidence of an association based on latency analysis at
.10- or .20-year lag, were consistent with the protracted
incubation periods in human prion disease, but might have
involved organs or tissues that are not known to be infectious in
sCJD [9,10]. Although case-control studies must be interpreted
with caution and there may be confounding of SP by BT, the
positive findings in relation to SP and BT may indicate a true risk
for sCJD c) As a third explanation, specific procedures at a shorter
latency could be a risk factor, e.g. retinal surgery with about a
Figure 1. Potential age-at-exposure-related susceptibility for the following different CJD forms and exposures: (a) Age-susceptibility
function for vCJD in the UK [12], and results from Table 1 for risk of sCJD from age at first hospital discharge associated with a registered, main
surgical procedure, at a lag of $20 years. (b) Reported estimated risks relating to 5- to 10-year age groups, after adjustment for dietary exposure to
bovine material and average incubation period established at 12.6 years for variant CJD in the UK [13], and plotted results from Table 1 for risk of
sCJD from age at first hospital discharge associated with an etiologically reclassified higher-risk or lower-risk procedure, at a lag of $20 years. (c)
Reported rate ratios of accidentally transmitted CJD (iCJD), for ever treatement vs never treatement with pituitary growth hormone (all treatments) at
specific ages [11]. Reference: all other ages at treatment. (d) Reported rate ratios of accidentally transmitted CJD (iCJD) for ever treatment vs never
treatment with pituitary growth hormone processed with the Hartree-modified Wilhelmi method (an hGH preparation associated with highest risk of
iCJD among hGH-treated cohorts) at specific ages [11]. Reference: all other ages at treatment.
doi:10.1371/journal.pone.0109412.g001
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mean 10-year lag or coronary surgery in the decade preceding
sCJD onset. The interpretation of these findings required an
assessment of specific, speculative hypotheses. Possibilities include
the direct spread of prions to the retina, or the confounding by risk
factors shared by coronary disease and sCJD [6,14]. For details we
refer the reader to our abovementioned review.
Public Health implications
We have previously estimated a population-attributable pro-
portion of surgically transmitted sCJD in Denmark and Sweden of
18%. This estimate was based mainly on surgery performed on
middle-aged and elderly patients [6]. If susceptibility is age-related,
as the present analysis indicate, the population-attributable
fraction was underestimated. This idea is based on the fact that
under-registration of SP prior to 1970 was highest for those first
exposed at ages ,30 years, and that positive life-time surgical
history in the UK at these ages reaches 60% [23]. Hence, risk of
sCJD might be highest for ages at surgery not completely covered
by our study. Estimating the public health impact would require a
study update to be conducted after a 10-year interval, ie, at the
present, to cover surgery at lower ages and infrequent, high-risk
procedures such as neurosurgery.
Our results may imply that written recommendations for
prevention, such as the need for single-use equipment, and for
organizational measures may be particularly relevant for young
surgical patients [24]. In addition, middle-aged and elderly
patients inadvertently exposed to potentially contaminated instru-
ments might not qualify as "at-risk persons for public health
purposes", in view of their lower risk of acquiring sCJD. The
results of this study would also support the need for EU Member
States to implement continued surveillance of and public health
research into all CJD forms, and the recording of patients’
complete surgical histories.
To sum up, the results of this study suggest that, in line with
reported findings for iCJD and vCJD, there is an age-at-exposure-
related susceptibility for risk of sCJD from routine surgery. This
observation is relevant for epidemiologic research, clinical
guidance to prevent CJD transmission in medical settings, and
CJD surveillance.
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